v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A  preferred stock
Series A  preferred stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2025   10,000 170,111,593      
Beginning balance at Mar. 31, 2025 $ 707,447 $ 0 $ 16 $ 1,945,495 $ 1,459 $ (1,239,523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     957,583      
Stock options exercised and restricted stock units vested and settled 2,918     2,918    
Capital contribution – stock-based compensation 115     115    
Stock-based compensation 18,395     18,395    
Foreign currency translation adjustments 278       278  
Net loss (120,613)         (120,613)
Ending balance (in shares) at Jun. 30, 2025   10,000 171,069,176      
Ending balance at Jun. 30, 2025 608,540 $ 0 $ 16 1,966,923 1,737 (1,360,136)
Beginning balance (in shares) at Mar. 31, 2026   10,000 203,940,353      
Beginning balance at Mar. 31, 2026 852,592 $ 0 $ 20 2,596,971 730 (1,745,129)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     2,324,525      
Stock options exercised and restricted stock units vested and settled 22,251     22,251    
Capital contribution – stock-based compensation 240     240    
Stock-based compensation 13,534     13,534    
Foreign currency translation adjustments (5)       (5)  
Net loss (153,224)         (153,224)
Ending balance (in shares) at Jun. 30, 2026   10,000 206,264,878      
Ending balance at Jun. 30, 2026 $ 735,388 $ 0 $ 20 $ 2,632,996 $ 725 $ (1,898,353)